Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Stock Sells Off after Announcement Tongjitang Chinese...
To Develop New Drugs for Cancer and Inflammation --...
A traditional Chinese medicine, delisheng, proved to be...
Tongjitang Pharmaceuticals (NYSE: TCM)...
Tongjitang Chinese Medicines Company reported decent...
November 9, 2007 – Investment in China biophama...
For a change, a China-based biopharma released a Q3...
The dollar value of China’s pharmaceutical market...
China's economy made an indelible impression on the world...
The ChinaBio® Stock Index, comprised of 17...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
